Newspatrolling.com News cum Content Syndication Portal Online
28 April 2025, Bengaluru: IOL Chemicals and Pharmaceuticals Limited (IOL), a leading manufacturer of pharmaceutical (APIs) and specialty chemicals, announced that it has received approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA), China, for its product Ibuprofen. This approval authorizes the Company to export its Ibuprofen API to the Chinese market.
Ibuprofen is a widely used non-steroidal anti-inflammatory drug (NSAID) known for its effectiveness in relieving pain, reducing inflammation, and lowering fever. With this certification, IOL will be able to cater to the growing demand for high-quality APIs in China, further strengthening its global footprint.
IOL maintains a diversified portfolio of more than 13 APIs, including Metformin Hydrochloride, Clopidogrel Bisulfate Form II, Pantoprazole Sodium, Losartan Potassium, among others. The Company remains committed to expanding its international reach through quality manufacturing and regulatory excellence.
About IOL Chemicals and Pharmaceuticals Limited (IOLCP)
Established in 1986 and listed on the National Stock Exchange of India Ltd (Code: IOLCP) and BSE Ltd (Code: 524164), IOL Chemicals and Pharma is one of the leading pharmaceutical (APIs) Companies and a significant player in the specialty chemicals space with world-class facilities. IOLCP has a wide presence across major therapeutic categories like pain management, anti-convulsants, anti-diabetes, anti-cholesterol and anti-platelets.
The Company’s product portfolio includes APIs; Ibuprofen, Metformin, Fenofibrate, Clopidogrel, Lamotrigine, Pantoprazole, Paracetamol and specialty chemicals such as Ethyl Acetate, Iso Butyl Benzene, Mono Chloro Acetic Acid and Acetyl Chloride.
The company is the World’s largest producer of Ibuprofen with an installed capacity of 12,000 TPA and having backward integrated manufacturing facility. The Company has DSIR-approved R&D which is fully equipped to validate existing processes.
The Central and State Government approved Effluent Treatment Plant (ETP) had been set up with Zero Liquid Discharge (ZLD) system along with a 17 MW captive Co-Generation plant for self-reliance. The Company is ISO 9001:2015, 14001:2015 and BS OHSAS 18001:2007 certified.
IOLCP’s overseas customers are spread out across several countries including the UK, Belgium, Hungry, Spain, Germany, Italy, Netherlands, Switzerland, Poland, Ireland, USA, Peru, Brazil, Argentina, Colombia, Indonesia, South Korea, Thailand, Bangladesh, Turkey, U.A.E., China, Hong Kong, Egypt etc. Products are sold primarily to Branded Generic formulators both in India & Overseas.
